Navigation Links
Orexigen® Therapeutics Reports Third Quarter Financial Results
Date:11/8/2011

>Anticipated reduction in predicted 10-year cardiovascular risk among Contrave treated patients from the Phase 3 COR program using a variety of validated risk models.
  • An imaging study showing that Contrave activated regions of the brain involved in controlling the response to food cues.
  • New analyses from the COR-I and COR-BMOD Phase 3 studies highlighting weight loss among subjects completing one year of therapy.  

  • The Company continues to expect cash expenditures for the second half of 2011 to be substantially lower than for the first half of 2011. The Company does anticipate a substantial increase in planned expenditures in 2012 as the major activities for the CVOT get underway once the details of the protocol are finalized and a clinical research organization to execute the trial is engaged.  The Company plans to provide a more detailed update on the specifics of the trial as well as additional financial guidance in the first quarter of 2012.

    About ContraveContrave, an investigational combination therapy of naltrexone HCl and bupropion HCl, was studied for its ability to help people with obesity initiate and sustain weight loss of at least 5 percent of their starting body weight in one year. Contrave was submitted for U.S. regulatory approval in March 2010. The original submission was based on multiple clinical trials that evaluated Contrave in more than 4500 patients. Orexigen received a Complete Response letter from the FDA on January 31, 2011.

    About Orexigen Therapeutics Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Contrave has completed Phase 3 clinical trials, and the Company's other product candidate, Empatic(TM), has completed Phase 2 clinical trials. Each of the components of the Company's product candidates has already received regulatory approval and has been commercialized previously. Further information about the Company can be found at '/>"/>

    SOURCE Orexigen Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Orexigen® Therapeutics Announces Upcoming Data Presentations at the 28th Annual Scientific Meeting of The Obesity Society
    2. Orexigen® Therapeutics Schedules November 3, 2010 Webcast Discussion of Financial Results for the Third Quarter Ended September 30, 2010
    3. Orexigen® Therapeutics to Present at JP Morgan Healthcare Conference
    4. Orexigen® Therapeutics Announces Corporate Realignment
    5. Orexigen® Therapeutics Announces Upcoming Data Presentation at the American College of Cardiology Annual Scientific Meeting
    6. Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring
    7. Orexigen® Therapeutics Announces Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
    8. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    9. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
    10. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
    11. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/22/2014)...   BioTE Medical , a leading provider ... pellets, today announced the addition of Dr. ... Rouzier is joining the BioTE Medical Advisory Board ... Rouzier was residency trained in Family Medicine and ... certified emergency physician still practicing at a large ...
    (Date:7/22/2014)... (PRWEB) July 22, 2014 CTD Holdings, ... the pharmaceutical, medical device, cosmetics, and other markets, announced ... with a group of qualified private investors led by ... , The transaction involved the signing of ... 1,725,000 shares of Common Stock at a price per ...
    (Date:7/22/2014)... Rice Lake Weighing Systems ... NCSL International Workshop and Symposium July 28-31 in ... pressure instrumentation, OIML M1 weights, precision lab weights, ... sets, Essential Weights™. , NCSL International was formed ... solving the common problems faced by measurement and ...
    (Date:7/22/2014)... (PRWEB) July 22, 2014 Two new ... Board of Directors at its annual Shareholders Meeting on ... Information Officer of The PFM Group, and Stephen T. ... Center also announced the election of Michael A. DiPiano, ... Vice Chair and Richard P. Jaffe, Esq., of Duane ...
    Breaking Biology Technology:Dr. Neal Rouzier Joins BioTE Medical 2Dr. Neal Rouzier Joins BioTE Medical 3CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3Rice Lake Weighing Systems Showcases Metrology Solutions for the 2014 NCSL International Workshop & Symposium 2Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3
    ... average 2006 super bowl commercial is unattainable for most ... for small business. , ,Using an Internet-based advertising agency ... a comprehensive TV advertising campaign in less than a ... You can purchase a pre-packaged ad from their ad ...
    ... University of Wisconsin-Madison's undergrad engineering contest was swept this ... solar energy collector that concentrates the sun's rays. , ... Friday in both the Schoofs Prize for Creativity and ... the mirrors that many current solar systems use to ...
    ... Quad Graphics, a printer of magazines, catalogs, books, direct ... tools for clients into a new business unit called ... Jaeger, who also serves as Quad Graphics' vice president ... QuadSystems is backed by the capabilities of 260 corporate ...
    Cached Biology Technology:Local TV advertising - Super Bowl vs. super bargain 2Local TV advertising - Super Bowl vs. super bargain 3Local TV advertising - Super Bowl vs. super bargain 4Concentrated solar energy project wins Innovation Days prizes 2
    (Date:7/23/2014)... habit of getting tangled and forming knots. Scientists study ... to disentangle them (e.g. useful for gene sequencing techniques). ... Studies (SISSA) in Trieste and his team have been ... and their dynamics. In their latest paper, just published ... with Marco Di Stefano, first author and PhD student ...
    (Date:7/23/2014)... available in German . ... for orientation, some of which might be very different ... polarization pattern produced by sunlight in the atmosphere to ... Planck Institute for Ornithology in Seewiesen, Germany, and Queen,s ... a night active mammal, the greater mouse-eared bat, has ...
    (Date:7/23/2014)... Currently, no cure exists for Alzheimer,s disease, the ... Americans. But scientists are now reporting new progress ... cancer treatment, that shows promise as a potential ... ACS, Journal of Medicinal Chemistry . , ... that in a healthy brain, the protein known ...
    Breaking Biology News(10 mins):Bats use the evening sky's polarization pattern for orientation 2
    ... Anthropogenic CO 2 emissions, in addition to causing ... them to turn progressively acidic. This change has severe ... in the latest edition of the journal Science ... of the Earth,s oceans has undergone profound changes, although none ...
    ... close proximity are substantially more different genetically than humans ... today in PLoS Genetics . The study suggests ... use in chimpanzee conservation, with the potential to identify ... the provenance of a sample of bush meat. ...
    ... a unique part of the animal kingdom, corals have ... Great Barrier Reef. Scientists from the Australian Institute of ... reproductive strategy in corals, adding another dimension to our ... published today in the prestigious international journal Science ...
    Cached Biology News:Oceans acidifying faster today than in past 300 million years 2Nearby chimpanzee populations show much greater genetic diversity than distant human populations 2Nearby chimpanzee populations show much greater genetic diversity than distant human populations 3Breaking up isn't hard to do -- the secret lives of corals on dark and stormy nights 2
    ... microRNA expression profiling and built on ... on-chip synthesis platform. These microarrays are ... microRNA Expression Profiling Service. ... Microarray contains all known maize microRNAs ...
    ... Agilent 6850 Networked GC is an excellent choice ... of a standard dual-channel GC, this one-channel workhorse ... in the space of one. You get all ... GC analyses in an instrument that has the ...
    ... The 6820 GC system combines world-class ... Chemical QA/QC software, Agilents world-renowned support and ... consumables and supplies--a combination that lets you ... decisions based on dependable data. The Agilent ...
    ... In the six short years since publication ... John Walkers widely acclaimed Protein Protocols Handbook, ... in protein biochemistry. In recognition of the ... the rapid evolution of new methodologies directed ...
    Biology Products: